๐Ÿฉบ
Premature Ejaculation โ€” Assessment & Management in Primary Care Lifelong vs acquired ยท EAU/ISSM guideline-aligned ยท Pharmacological & behavioural approaches
Progress 0 / 9
The full reasoning pathway โ€” premature ejaculation is common and treatable: distinguish lifelong from acquired, address contributors, and offer behavioural and pharmacological options. Support the couple, and safety-net.StartDecisionInvestigateActionReferStop / Admit
PresentationPremature ejaculation
Lifelong vs acquired, intravaginal latency, distress, ED, relationship factors. Exclude prostatitis/thyroid contributors.
Step 1 ยท Safety โ€” underlying causeUnderlying / secondary cause?
Acquired PE with erectile dysfunction, prostatitis symptoms, or thyroid features โ†’ treat the underlying condition.
YES
Stop ยท EscalateTreat cause
Address comorbid ED, prostatitis or hyperthyroidism first.
NO
AssessBy pattern
History + examination localise the cause.
Step 3 ยท treatment options
Behavioural
First-line
Stop-start / squeeze techniques, psychosexual therapy; address anxiety/relationship factors.
Pharmacological
Options
Topical anaesthetics; SSRI (dapoxetine on-demand or daily SSRI off-licence); treat coexisting ED.
Treat contributors
Optimise
Manage ED, prostatitis, thyroid; reduce performance anxiety.
ReferEscalation
Psychosexual services for refractory or relationship-related cases; manage coexisting ED and underlying conditions.
Step 8 ยท lifestyle & couple support
Step 8 ยท Lifestyle & couple supportReduce anxiety, involve the partner
Behavioural techniques (stop-start, squeeze), pelvic-floor exercises, and involving the partner reduce performance pressure. Address anxiety, stress and relationship factors; reduce alcohol/recreational drugs; encourage open communication. Normalise that PE is common and treatable to reduce shame. Optimise general and cardiovascular health (relevant to coexisting ED).
Step 9 ยท review & safety-net
Step 9 ยท Review & safety-netReassess & when to escalate
Review response to behavioural ยฑ pharmacological treatment and tolerability (SSRI/dapoxetine side-effects). Reassess for an organic cause if PE is new/acquired โ€” treat coexisting ED, prostatitis or thyroid disease first. Refer to psychosexual services if persistent or causing significant relationship distress; screen mood, as PE commonly coexists with anxiety/depression.
โš ๏ธ Treat any coexisting erectile dysfunction first: men sometimes rush to ejaculate because of unreliable erections, so addressing ED can resolve apparent premature ejaculation.
1
Safety

Red Flags โ€” Exclude Underlying Medical Causes & Psychological Crisis

PE is usually primary (lifelong) or psychological, but new-onset or acquired PE may signal prostatitis, neurological disease, or significant psychological distress.

New-onset PE + lower urinary tract symptoms Frequency, urgency, dysuria, perineal pain, pelvic discomfort โ†’ Same-day or urgent urology (chronic prostatitis/pelvic pain syndrome โ€” causes acquired PE)
Suicidal ideation / severe depression PE causing significant relationship breakdown, social withdrawal, suicidal thoughts โ†’ Same-day mental health assessment. PE has high comorbidity with depression and anxiety.
New neurological symptoms PE acquired after neurological symptoms (paraesthesia, weakness, spasticity) โ†’ Neurological assessment (multiple sclerosis, spinal cord pathology โ€” disrupts ejaculatory control)
Thyroid symptoms New PE + hyperthyroid features (tremor, palpitations, weight loss, heat intolerance) โ†’ TFTs. Hyperthyroidism causes PE in up to 50% of affected men โ€” treat thyroid first.
Post-pelvic surgery PE following prostatectomy, bladder surgery, or pelvic radiotherapy โ†’ Urology. Post-surgical ejaculatory dysfunction is distinct from primary PE.
Relationship/domestic abuse If PE presenting in context of coercive control or partner pressure โ†’ Safe enquiry. Sexual dysfunction can be a manifestation of intimate partner violence dynamics.
Concurrent erectile dysfunction PE + ED together may indicate cardiovascular disease, diabetes, hypogonadism โ†’ Investigate both simultaneously. ED + PE = higher likelihood of organic cause.
Drug-related PE Check for PE onset coinciding with medications: tramadol (causes delayed ejaculation โ€” sometimes used therapeutically), antipsychotics, opioid withdrawal. Review full drug history.
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is present in up to 64% of men with acquired PE โ€” treating PE without treating prostatitis leads to treatment failure. Hyperthyroidism-induced PE resolves in 80% of cases with thyroid treatment alone โ€” prescribing dapoxetine or SSRIs without TFTs wastes resources and delays cure. Acquired PE (normal ejaculatory latency then new-onset PE) is a more specific indicator of organic disease than lifelong PE. Depression screening is mandatory โ€” PE has been associated with significantly elevated rates of suicidal ideation in several epidemiological studies, and this is underappreciated clinically.
2
Diagnose

Confirm & Characterise โ€” Validated Definition & History Taking

Use ISSM (International Society for Sexual Medicine) diagnostic criteria. Set the patient at ease โ€” normalise the consultation before taking the history.

ISSM definition
PE = ejaculation that always/nearly always occurs before or within approximately 1 minute of vaginal penetration (lifelong PE) OR a significant reduction in latency time to โ‰ค3 minutes (acquired PE), AND inability to delay, AND significant negative consequences (distress, bother, frustration, avoidance of sexual intimacy).
Intravaginal ejaculatory latency time (IELT)
Ask: "How long from penetration to ejaculation?" Average IELT = 5.4 minutes. PE threshold = โ‰ค1 min (lifelong) or โ‰ค3 min (acquired). Stop-watch recording optional but rarely practical.
Lifelong (primary) PE
Present from first sexual encounter. Every partner, every occasion. Likely neurobiological basis (serotonin receptor sensitivity, penile glans hypersensitivity). Responds well to pharmacological treatment.
Acquired (secondary) PE
Normal ejaculatory control previously, then new-onset PE. Triggers: prostatitis, relationship factors, ED, hyperthyroidism, psychological factors. Investigate for organic cause first.
Natural variable PE
Occasional PE in certain situations (stress, new partner, after abstinence). Not a disorder. Reassurance ยฑ behavioural techniques. No pharmacological treatment indicated.
Subjective PE
Normal IELT (3โ€“5 min) but patient perceives PE. Often associated with anxiety, unrealistic expectations (pornography-influenced), relationship issues. Psychosexual therapy first-line.
Partner impact
Always ask about partner's perspective if applicable. Relationship distress, partner anorgasmia, intimacy avoidance. Partner involvement in treatment improves outcomes significantly.
The ISSM 2014 evidence-based definition is important because PE is over-diagnosed in men with normal IELT but performance anxiety. Treating normal IELT with pharmacological agents risks medicalising normal variation and creating drug dependence. The IELT of 1 minute for lifelong PE is the only criterion with strong epidemiological evidence (95th centile for PE classification). Men with subjective PE (normal IELT + anxiety) have dramatically better outcomes from psychosexual therapy than from dapoxetine โ€” getting the subtype right prevents inappropriate prescribing. The consultation itself is therapeutic: normalising PE (affects 20โ€“30% of men at some point) reduces shame and improves treatment engagement.
3
Diagnose

Classify Subtype โ€” Drives Treatment Selection

The EAU (European Association of Urology) 2024 guidelines classify PE into four subtypes โ€” each requires a different primary treatment strategy.

Lifelong PE
From first intercourse. IELT <1 min. Always with every partner. Neurobiological basis (serotonergic hypofunction, penile hypersensitivity). Primary treatment: dapoxetine or daily SSRI. Behavioural techniques as adjunct.
Acquired PE
Normal history then PE develops. Triggers: CP/CPPS, ED, hyperthyroidism, relationship issues, psychological factors. Treat underlying cause first. Then add dapoxetine if residual PE.
Natural variable PE
Inconsistent, situational. Normal variation. Reassurance + psychoeducation. Avoid pharmacological treatment โ€” no disorder requiring medication.
Subjective PE
Normal IELT but perceived as PE. Anxiety/unrealistic expectations driven. Psychosexual therapy first-line. No pharmacological treatment unless severe anxiety component warrants SSRI.
Co-existing ED
PE + ED: treat ED first (PDE5i). Anxiety about losing erection often drives rapid ejaculation. When ED treated, PE may resolve. If persistent PE after ED treatment: add dapoxetine.
Psychological assessment
Screen with PHQ-9 (depression) and GAD-7 (anxiety) in all presentations. Treat comorbid depression/anxiety โ€” improves PE outcomes and patient wellbeing.
EAU guidelines emphasise that treating acquired PE without addressing the underlying cause is ineffective in most cases. Chronic prostatitis causing acquired PE may require alpha-blocker therapy (tamsulosin 400 mcg OD) alongside antibiotic treatment for Category II prostatitis, or alpha-blockers + physiotherapy for Category III โ€” PE often resolves. Treating PE with dapoxetine when the real cause is performance anxiety from ED will fail until the ED is treated. The most efficient use of a 10-minute appointment is establishing subtype in the first appointment and booking a follow-up or psychosexual therapy referral โ€” rather than immediately prescribing dapoxetine for all presentations.
4
Diagnose

Targeted Examination

Physical examination is not always required for clear lifelong PE, but is essential for acquired PE and when organic cause is suspected.

General examination
BMI, BP (cardiovascular risk โ€” shared risk factor for ED). Signs of thyroid disease (tremor, goitre, tachycardia, exophthalmos โ€” hyperthyroidism causes PE). Gynaecomastia (hypogonadism).
Genital examination
Phimosis (tight foreskin โ€” penile hypersensitivity, causes PE). Frenulum breve (tight frenulum โ€” pain/hypersensitivity on erection). Hypospadias (anatomical variant). Peyronie's disease (penile plaques โ€” affects sexual function).
Prostate assessment
If acquired PE + LUTS: DRE to assess prostate (tenderness = prostatitis, enlargement = BPH). Consider in all men >45 with acquired PE + urinary symptoms
Neurological
Bulbocavernosus reflex (S2-4 integrity โ€” test by squeezing glans and feeling anal sphincter contraction). Perineal sensation. If abnormal โ†’ neurology referral.
Secondary sex characteristics
Testicular size (small testes โ†’ hypogonadism), body hair distribution, voice. Relevant if concurrent ED or low libido suggesting testosterone deficiency.
Examination normal
For clear lifelong PE with no red flags: genital examination is optional but reassures patient and excludes anatomical causes. Can omit if patient prefers and history is classic.
Phimosis and frenulum breve are surgically correctable causes of PE โ€” missing them means prescribing lifelong medication for a surgically curable condition. Preputioplasty or frenuloplasty resolves PE in these cases. Prostatitis on DRE (exquisite tenderness of the prostate) changes management completely โ€” antibiotics (ciprofloxacin 500mg BD for 4 weeks for Category II) rather than dapoxetine becomes first-line. The examination also serves a therapeutic function: many men presenting with PE have significant body image concerns and genital anxiety โ€” a normal, matter-of-fact examination with reassurance that genitalia are anatomically normal reduces anxiety significantly.
5
Diagnose

Investigations โ€” Targeted, Not Routine

Lifelong PE with no red flags: minimal investigation needed. Acquired PE or concurrent ED: targeted investigation to exclude organic cause.

TFTs
If acquired PE
Hyperthyroidism is present in 50% of acquired PE cases. TSH suppressed + raised fT4 โ†’ treat thyroid first. Do not prescribe dapoxetine before checking TFTs in acquired PE
Fasting glucose + HbA1c
Diabetes causes autonomic neuropathy โ†’ ejaculatory dysfunction. Relevant if concurrent ED, obesity, risk factors. Diagnose and treat diabetes โ€” PE may improve.
Testosterone + LH
If low libido + PE + ED: check morning testosterone (low <8 nmol/L), LH (primary vs secondary hypogonadism). Testosterone replacement may improve overall sexual function.
Urine MC&S + PSA
If prostatitis suspected: MSU MC&S (bacteriuria in Category II prostatitis). PSA if age >50 + LUTS (prostate cancer can cause ejaculatory dysfunction). Discuss PSA pros/cons before testing.
Nocturnal penile tumescence
Not primary care investigation. Differentiates psychogenic from organic ED if concurrent ED is unclear. Secondary care.
When NOT to investigate
Classic lifelong PE, no red flags, normal examination, patient under 45 โ†’ no investigations required. Start treatment and review. Over-investigation delays treatment and increases anxiety.
The evidence for TFT testing in acquired PE is compelling: a systematic review found that treating hyperthyroidism normalised ejaculatory latency in 83% of men without additional PE-specific treatment. This represents a fully reversible cure โ€” prescribing dapoxetine instead means lifelong medication for a treatable condition. Testosterone deficiency rarely causes PE in isolation but frequently causes ED + reduced libido which creates a pattern of rapid ejaculation through anxiety about losing erection. Morning testosterone (7โ€“10am) is the correct timing as diurnal variation is significant โ€” an afternoon testosterone may be falsely low.
6
Refer

Referral Criteria

Most PE can be managed entirely in primary care. Refer for specialist psychosexual therapy, when organic cause requires specialist input, or when primary care treatment has failed.

Same-day mental health
Suicidal ideation secondary to PE-related distress ยท Severe depression requiring urgent psychiatric input ยท Domestic/relationship crisis
Urgent urology
Suspected prostatitis with haematospermia or systemic sepsis ยท Suspected anatomical abnormality requiring surgery (severe phimosis, frenulum breve) ยท PE post-pelvic surgery/radiotherapy
Psychosexual therapy
Subjective PE (normal IELT) โ†’ first-line referral ยท Significant relationship/partner issues ยท Treatment failure after 6 months pharmacological treatment ยท Patient preference ยท Natural variable PE requiring behavioural techniques
Routine urology
Acquired PE failing primary care treatment ยท Suspected prostatitis (CP/CPPS) unresponsive to antibiotics ยท PE + ED together unresponsive to PDE5i
Primary care management
Lifelong PE, acquired PE with no organic cause found, subjective PE with mild anxiety: start treatment in primary care. Review at 4 weeks, 3 months.
NHS psychosexual therapy services have variable availability โ€” in some areas waiting times exceed 6 months. Where waiting times are long, starting dapoxetine as a bridge while awaiting psychosexual therapy is appropriate and improves compliance with psychotherapy (reduced anxiety allows better engagement with therapy). Private psychosexual therapy (sex therapists registered with COSRT or UKCP) is faster โ€” worth signposting. Relationships Scotland and Relate provide couples therapy with psychosexual elements for patients with significant relationship impact. Frenuloplasty under local anaesthetic is a minor day-case urological procedure with extremely high satisfaction rates for PE secondary to frenulum breve.
7
Treat

Treatment Ladder โ€” Pharmacological & Behavioural

EAU 2024: combined pharmacological + behavioural treatment is more effective than either alone. Address both dimensions.

On-demand / as-needed
Dapoxetine 30mg First-line pharmacological
Take 1โ€“3 hours before intercourse. Licensed for PE in men 18โ€“64. Short-acting SSRI (Tยฝ 1.3h). Increases IELT 2โ€“3ร— from baseline. Max 30mg โ†’ 60mg if inadequate response. Max 1/day.
Daily maintenance
Paroxetine 10โ€“40mg OD Daily SSRI โ€” most effective
Most evidence for PE. Start 10mg OD, increase to 20โ€“40mg OD. Effect seen in 1โ€“2 weeks, maximal at 3โ€“4 weeks. IELT increase 6โ€“10ร— from baseline. Off-label for PE. Warn about discontinuation symptoms.
Topical โ€” penile hypersensitivity
EMLA cream / Fortacin spray Topical anaesthetic
EMLA (lidocaine/prilocaine) 2.5g applied to glans 20 mins pre-intercourse, wipe off. Fortacin 150mg/mL spray: 3 actuations to glans, wait 5 min, wipe. Apply condom to prevent partner anaesthesia.

Full treatment ladder:
Step 1Psychoeducation + behavioural techniques โ€” Stop-start technique (Semans) or squeeze technique (Masters & Johnson). Practice alone first, then with partner. Takes 4โ€“8 weeks to show benefit. Pelvic floor exercises (Kegel) โ€” improves voluntary ejaculatory control. NNT ~3 for combined techniques.
Step 2Dapoxetine 30mg on-demand (1โ€“3h before intercourse). Use when intercourse anticipated. Provides immediate benefit. Escalate to 60mg if 30mg inadequate after 4 uses. Contraindications: MAOI use, SSRIs/SNRIs, cardiac disease, syncope history, age >65.
Step 3Topical anaesthetic โ€” EMLA cream or Fortacin spray (lidocaine 150mg/mL, licensed for PE). Can combine with dapoxetine for refractory cases. Reduces glans hypersensitivity. Wipe off before penetration โ€” prevent partner anaesthesia. Use with condom ideally.
Step 4Daily SSRI (off-label) โ€” Paroxetine 10โ€“40mg OD (most evidence) or sertraline 50โ€“200mg OD or fluoxetine 20โ€“40mg OD. Better efficacy than on-demand dapoxetine for very short IELT. Warn: 2โ€“3 weeks latency, discontinuation syndrome (especially paroxetine), sexual side effects on partner (anorgasmia concern).
Step 5Combination therapy โ€” Daily SSRI + dapoxetine on-demand (use cautiously โ€” serotonin syndrome risk if both SSRIs, though dapoxetine + paroxetine is commonly used in practice with monitoring). Add psychosexual therapy to any pharmacological regimen. PDE5i (sildenafil/tadalafil) if concurrent ED.
Dapoxetine contraindications
MAOIs (within 14 days) ยท Concurrent SSRIs/SNRIs (serotonin syndrome) ยท Significant cardiac disease, prolonged QTc ยท History of syncope or orthostatic hypotension ยท Moderate-severe hepatic impairment ยท Age <18 or >65
Dapoxetine increases mean IELT from 0.9 min to 2.8 min (30mg) and 3.1 min (60mg) in RCTs โ€” approximately a 3ร— improvement. However, patient-reported satisfaction is highest when behavioural techniques are added. Daily paroxetine increases IELT 6โ€“10ร— (from 0.9 min to 6โ€“9 min) โ€” superior pharmacological efficacy, but requires daily dosing and carries discontinuation syndrome risk. The combination of dapoxetine + topical anaesthetic has additive effect via different mechanisms (central serotonergic delay + peripheral sensory threshold increase). Pelvic floor muscle training alone in one RCT achieved 61% resolution rate in acquired PE at 12 weeks โ€” often overlooked as a standalone treatment. Fortacin (licensed topical spray) offers more consistent dosing than EMLA cream and is preferred by many patients for convenience.
8
Lifestyle

Behavioural Techniques, Psychological Strategies & Lifestyle

Behavioural techniques are first-line for all PE subtypes and should be prescribed as concretely as medication. Written resources or signposting to reputable online materials aids adherence.

Stop-start technique (Semans) Stimulate to point of near-ejaculation, pause until sensation reduces, restart. Repeat 3 times before ejaculation. Practice alone first (2 weeks), then with partner. Teaches recognition and control of point of ejaculatory inevitability.
Squeeze technique Partner applies firm pressure to frenulum/glans for 10โ€“20 seconds at point of near-ejaculation until urge passes. Reduces arousal. Same progression as stop-start. Partner involvement significantly improves outcomes.
Pelvic floor exercises Identify PC muscle (muscle used to stop urination midstream). Contract for 3 seconds, relax for 3 seconds. 3 sets ร— 10 reps, 3ร—/day. Results in 4โ€“8 weeks. Free NHS resource: NHS pelvic floor exercises leaflet.
Mindfulness & sensate focus Sensate focus (Masters & Johnson): gradual reintroduction of physical intimacy without performance pressure. Reduces anticipatory anxiety, the most common PE amplifier. Refer to psychosexual therapist for structured delivery.
Masturbation before intercourse Masturbating 1โ€“2 hours before anticipated intercourse reduces sensitivity and extends latency during subsequent intercourse (refractory period exploited). Practical, accessible, effective for mild cases.
Condom use Thicker condoms (e.g., Durex Extra Safe) reduce penile sensitivity by 20โ€“30%. Combination with dapoxetine or EMLA enhances effect. Practical, free, no side effects.
Anxiety management PE is self-reinforcing via performance anxiety. CBT (especially cognitive restructuring of catastrophic beliefs about PE). Exercise reduces cortisol and anxiety. Sleep hygiene. Address alcohol use โ€” alcohol worsens PE control despite short-term disinhibition.
Partner communication Open discussion with partner about PE reduces shame and improves intimacy. Partners often feel responsible โ€” psychoeducation for both. Focus on non-penetrative intimacy reduces performance pressure. NHS relationship therapy available via GP referral.
The original Masters & Johnson (1970) study reported 97% success with stop-start/squeeze + psychosexual therapy โ€” though modern long-term follow-up data is less impressive (relapse rate 75% at 3 years without maintenance). Pelvic floor training (Pastore et al., 2014 RCT) achieved 64% cure rate at 12 weeks โ€” comparable to dapoxetine without drug side effects or cost. The mechanism: voluntary contraction of puborectalis and bulbocavernosus muscles inhibits the autonomic ejaculatory reflex. Partner-involved treatment achieves 3ร— better outcomes than individual treatment โ€” routinely including the partner (if present and willing) in the consultation or providing them with written information should be standard practice. Alcohol use is commonly misunderstood: while acute intoxication may delay ejaculation in some men, chronic alcohol use damages pudendal nerve function and worsens PE long-term.
9
Safety

Follow-Up, Monitoring & Safety-Netting

PE is a chronic condition for most men โ€” long-term management is the norm. Review treatment response, side effects, and psychological wellbeing at regular intervals.

4 weeks
Review dapoxetine response: adequate (IELT improved + satisfied) โ†’ continue, review in 3 months. Inadequate โ†’ escalate to 60mg, add topical, consider daily SSRI. Review side effects: nausea, dizziness, diarrhoea, insomnia (common with dapoxetine, usually mild).
3 months
Full review: IELT, patient satisfaction, partner satisfaction (if applicable), psychological wellbeing, adherence to behavioural techniques. PHQ-9/GAD-7 re-screen. Consider dose reduction or holiday if good response.
6 months
If daily SSRI used: review need, consider trial withdrawal (taper paroxetine over 4 weeks โ€” never stop abruptly โ€” discontinuation syndrome). If acquired PE: re-assess for treated organic cause.
Dapoxetine monitoring
Syncope risk: instruct patient to take first dose sitting down and monitor for 2 hours. Avoid if on antihypertensives (additive hypotension). Avoid alcohol with dapoxetine (risk of syncope, nausea).
Safety-net โ€” same day
Syncope after dapoxetine dose ยท Signs of serotonin syndrome (fever, myoclonus, agitation, tachycardia) if on other serotonergic drugs ยท Worsening depression or suicidal ideation
Treatment holiday
After 6โ€“12 months of successful treatment, trial drug holiday (maintain behavioural techniques). Many men do not require lifelong pharmacotherapy. Review if relapse occurs.
Ongoing follow-up
Annual review for men on long-term dapoxetine or daily SSRI. Reassess diagnosis and treatment need. Screen for new organic causes if acquired PE returns.
Dapoxetine syncope: in clinical trials, orthostatic syncope occurred in 0.2% of patients โ€” mostly on first use, in hot environments, or after alcohol. The first-dose sitting observation is not bureaucratic โ€” it prevents a dangerous fall. Paroxetine discontinuation syndrome is one of the most distressing SSRI withdrawal syndromes โ€” "brain zaps" (electric shock sensations), severe nausea, extreme anxiety, nightmares. Tapering over 4โ€“6 weeks prevents this. Many men can successfully discontinue pharmacotherapy after mastering behavioural techniques โ€” treatment should have a clear end-point in the management plan, not default to lifelong prescribing. Men who achieve good control often find confidence improvements generalise to reduced anxiety, improved relationships, and enhanced sexual satisfaction for both partners โ€” the treatment benefit extends well beyond IELT.
Educational use only. Pathway based on EAU Guidelines on Sexual and Reproductive Health (2024), ISSM PE Definition (2014), BSSM (British Society for Sexual Medicine) Guidelines, NICE CKS Erectile Dysfunction (cross-reference). Always adapt to individual patient context and local formulary.